SS Innovations International, Inc. (NASDAQ:SSII – Get Free Report) CEO Srivastava Sudhir sold 33,333 shares of the stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $3.00, for a total transaction of $99,999.00. Following the completion of the transaction, the chief executive officer owned 108,520,928 shares of the company’s stock, valued at $325,562,784. This represents a 0.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
SS Innovations International Trading Down 1.5%
Shares of NASDAQ:SSII opened at $3.22 on Thursday. The company has a 50 day moving average of $3.65 and a 200-day moving average of $4.06. The firm has a market cap of $645.22 million, a P/E ratio of -53.67 and a beta of -1.94. SS Innovations International, Inc. has a twelve month low of $3.11 and a twelve month high of $10.00.
SS Innovations International (NASDAQ:SSII – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.01) EPS for the quarter. The company had revenue of $13.94 million for the quarter. SS Innovations International had a negative net margin of 23.73% and a negative return on equity of 26.77%.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on SS Innovations International
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the company. PNC Financial Services Group Inc. purchased a new stake in shares of SS Innovations International during the 3rd quarter worth about $56,000. Jane Street Group LLC bought a new stake in shares of SS Innovations International in the 4th quarter valued at approximately $63,000. IFC & Insurance Marketing Inc. acquired a new position in SS Innovations International in the fourth quarter worth approximately $64,000. Goldman Sachs Group Inc. bought a new position in SS Innovations International during the fourth quarter valued at approximately $68,000. Finally, Envestnet Asset Management Inc. bought a new position in SS Innovations International during the third quarter valued at approximately $71,000.
SS Innovations International Company Profile
AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.
See Also
- Five stocks we like better than SS Innovations International
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.
